tradingkey.logo

tradingkey.logo
怜玢


Aytu Biopharma Inc

AYTU
りォッチリストに远加
1.830USD
+0.020+1.10%
終倀 11-06 16:00ET
19.89M時䟡総額
損倱額盎近12ヶ月PER

Aytu Biopharma Incに぀いお 䌁業名

Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.

Aytu Biopharma Inc プロフィヌル


䌁業コヌドAYTU
䌚瀟名Aytu Biopharma Inc
䞊堎日Oct 20, 2017
最高経営責任者「CEO」Disbrow (Joshua R)
埓業員数82
蚌刞皮類Ordinary Share
決算期末Oct 20
本瀟所圚地7900 E. Union Avenue
郜垂DENVER
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号80237
電話番号17204376580
りェブサむトhttps://aytubio.com/
䌁業コヌドAYTU
䞊堎日Oct 20, 2017
最高経営責任者「CEO」Disbrow (Joshua R)

Aytu Biopharma Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
76.57K
+19.59%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
74.74K
+33.45%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
56.10K
+35.65%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
31.15K
+32.10%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
29.82K
+33.53%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
76.57K
+19.59%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
74.74K
+33.45%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
56.10K
+35.65%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
31.15K
+32.10%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
29.82K
+33.53%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--

よくある質問

Aytu Biopharma Incの䞊䜍5名の株䞻は誰ですか


Aytu Biopharma Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Jarrett T. (Josh) Disbrow

Aytu Biopharma IncAYTUの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Aytu Biopharma Incの株匏を保有しおいる機関は69瀟あり、保有株匏の総垂堎䟡倀は玄3.87Mで、党䜓の36.10%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-493525.00増加しおいたす。

Aytu Biopharma Incの最倧の収益源は䜕ですか


2026Q1においお、ADHD portfolio郚門がAytu Biopharma Incにずっお最倧の収益を生み出しおおり、その金額は9.09Mで、党収益の73.27%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。